Neoadjuvant Endocrine Therapy in Breast Cancer - Wikidata - awgldk - TriplyDB

Neoadjuvant Endocrine Therapy in Breast Cancer

Neoadjuvant Endocrine Therapy in Breast Cancer

http://www.wikidata.org/entity/Q34096272

about

Neoadjuvant Endocrine Therapy in Breast Cancer

http://www.wikidata.org/entity/Q34096272

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Neoadjuvant Endocrine Therapy in Breast Cancer

@ast

Neoadjuvant Endocrine Therapy in Breast Cancer

@en

Neoadjuvant Endocrine Therapy in Breast Cancer

@nl

type

label

Neoadjuvant Endocrine Therapy in Breast Cancer

@ast

Neoadjuvant Endocrine Therapy in Breast Cancer

@en

Neoadjuvant Endocrine Therapy in Breast Cancer

@nl

prefLabel

Neoadjuvant Endocrine Therapy in Breast Cancer

@ast

Neoadjuvant Endocrine Therapy in Breast Cancer

@en

Neoadjuvant Endocrine Therapy in Breast Cancer

@nl

P1433

Q34096272-82264BAE-43FD-4813-AC93-E52C348DB00E

P1476

Q34096272-0424236C-C2BE-4F48-AB00-996F9D4B17D6

P2093

Q34096272-434FE2CF-C8F7-4DFE-8D8B-175376B70529

P2860

Q34096272-02C286F5-658B-488D-BBC3-798558E97FA2

Q34096272-0A3D9F51-2C61-43EF-94D8-8F51CAF29B93

Q34096272-1176F9A9-9D0F-4C22-B383-D0E53F17B249

Q34096272-17456D41-6148-44B8-ABBD-97EE374091C2

Q34096272-253A0240-76ED-4669-80F5-C70506213814

Q34096272-3BD2C17F-1AAC-46F9-B1FC-4D06E6AA7731

Q34096272-41719F95-46CC-4DED-8C38-ECAEB5C4E6D5

Q34096272-68232BA8-C5D8-487A-87A9-7A4F81F52692

Q34096272-7CE0FF90-9B29-4190-B286-85D42255C988

Q34096272-894E704A-ED6B-4B49-A89A-37CC5080A33B

P304

Q34096272-F83B1E84-5306-42DA-8454-F888395A42FE

P31

Q34096272-0ADD539E-5A11-449E-B370-2DFB4542AA9A

P356

Q34096272-E6B1D7F0-14F3-4C21-B56B-BB341ED01C68

P433

Q34096272-694D9EBD-F0B1-4106-A648-CF84E4895535

P478

Q34096272-2D38E22C-B128-4AE8-B044-818AFD741B7C

P577

Q34096272-8E96E53F-C7C8-463C-9766-A10F8E7CA2C9

P5875

Q34096272-21752871-8C54-48B1-862D-13DEF31CC1F0

P698

Q34096272-CF3C0EE0-1D4C-48AE-848E-AD77DC20C0D8

P932

Q34096272-08D3D1A9-B1A1-46B8-915E-E41490D3DEC8

P356

P1433

P1476

Neoadjuvant Endocrine Therapy in Breast Cancer

@en

P2093

Christian F Singer

http://www.w3.org/2001/XMLSchema#string

P2860

Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.

Endocrine and clinical endpoints of exemestane as neoadjuvant therapy.

Hormonal therapy in postmenopausal women with breast cancer.

Fulvestrant (Faslodex) -- how to make a good drug better.

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study.

Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial.

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer.

P304

303-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000152005

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46170735

http://www.w3.org/2001/XMLSchema#string

P698

20824024

http://www.w3.org/2001/XMLSchema#string

P932

2931101

http://www.w3.org/2001/XMLSchema#string